Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Michigan Rogel Cancer Center
With
National Cancer Institute (NCI)
This study is a randomized control pilot trial involving 60 women newly diagnosed with early-stage breast cancer who are finishing primary treatment. Participants will be randomized either to the intervention arm (CCC website that provides information on team-based follow-up care for both cancer surveillance and preventive care) or the control arm (static online survivorship care plan template, adapted from the ASCO breast cancer survivorship template). The feasibility and acceptability of the tool and correlations with patient-reported outcomes will be assessed 3 months following the completion of a baseline survey via an online follow-up survey.
Age
21–84
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Diagnosed with early Stage (0-IIB) breast cancer
Must be a patient of a University of Michigan Breast Cancer Oncologist
Must be completing primary cancer treatment and transitioning into survivorship
Must be able to speak, read and write in English
Must have access and the ability to use the internet
You may not be if
Diagnosed with stage III or IV breast cancer
Unable to speak, read, and write in English
Clareo Health | The ConnectedCancerCare Pilot Study (CCC)
